Total Payments
$34,170
2024 Payments
$3,752
Companies
59
Transactions
1,288
Medicare Patients
780
Medicare Billing
$13,745
Payment Breakdown by Category
Food & Beverage$33,672 (98.5%)
Education$498.86 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $33,672 | 1,264 | 98.5% |
| Education | $498.86 | 24 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $6,258 | 216 | $0 (2024) |
| ABBVIE INC. | $4,002 | 125 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,279 | 77 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,166 | 87 | $0 (2024) |
| PFIZER INC. | $2,108 | 95 | $0 (2024) |
| Novo Nordisk Inc | $1,916 | 61 | $0 (2024) |
| Lilly USA, LLC | $1,757 | 95 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,650 | 53 | $0 (2024) |
| Amarin Pharma Inc. | $1,247 | 66 | $0 (2022) |
| Amgen Inc. | $1,199 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,752 | 153 | AstraZeneca Pharmaceuticals LP ($948.11) |
| 2023 | $4,952 | 179 | GlaxoSmithKline, LLC. ($769.73) |
| 2022 | $4,375 | 149 | Novo Nordisk Inc ($723.17) |
| 2021 | $4,767 | 207 | AstraZeneca Pharmaceuticals LP ($819.23) |
| 2020 | $3,227 | 161 | AstraZeneca Pharmaceuticals LP ($963.27) |
| 2019 | $5,120 | 149 | AstraZeneca Pharmaceuticals LP ($980.13) |
| 2018 | $4,010 | 142 | AstraZeneca Pharmaceuticals LP ($502.26) |
| 2017 | $3,967 | 148 | AstraZeneca Pharmaceuticals LP ($765.38) |
All Payment Transactions
1,288 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.61 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: UROLOGY | ||||||
| 12/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: DIABETES | ||||||
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: DIABETES | ||||||
| 11/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: Oncology | ||||||
| 11/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Obesity | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Endocrinology | ||||||
| 11/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.04 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: UROLOGY | ||||||
| 10/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Endocrinology | ||||||
| 10/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.59 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 117 | 121 | $4,239 | $3,134 |
| 2022 | 4 | 114 | 121 | $3,459 | $2,533 |
| 2021 | 9 | 288 | 323 | $10,104 | $5,071 |
| 2020 | 7 | 261 | 302 | $8,618 | $3,007 |
Total Patients
780
Total Services
867
Medicare Billing
$13,745
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $1,635 | $1,602 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 40 | $1,185 | $1,161 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 44 | 47 | $1,335 | $288.12 | 21.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 19 | 19 | $84.00 | $82.32 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 40 | 43 | $1,280 | $1,259 | 98.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 18 | 19 | $734.00 | $723.28 | 98.5% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 15 | 15 | $305.00 | $298.90 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 41 | 44 | $1,140 | $251.58 | 22.1% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 15 | 15 | $990.00 | $990.00 | 100.0% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 23 | 23 | $890.00 | $890.00 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 28 | 29 | $905.00 | $589.76 | 65.2% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 15 | 15 | $550.00 | $521.14 | 94.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 54 | 60 | $1,540 | $513.10 | 33.3% |
| 85049 | Platelet count, automated test | Office | 2021 | 85 | 109 | $3,134 | $488.32 | 15.6% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 12 | 12 | $485.00 | $485.00 | 100.0% |
| 90674 | Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free | Office | 2021 | 14 | 14 | $410.00 | $409.22 | 99.8% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 42 | 46 | $1,200 | $184.92 | 15.4% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 11 | 11 | $791.00 | $782.28 | 98.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 29 | 29 | $800.00 | $572.75 | 71.6% |
| 85049 | Platelet count, automated test | Office | 2020 | 94 | 121 | $3,479 | $538.57 | 15.5% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 25 | 25 | $496.00 | $393.44 | 79.3% |
| 81000 | Manual urinalysis test with examination using microscope | Office | 2020 | 65 | 78 | $2,032 | $311.80 | 15.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 24 | 24 | $600.00 | $299.76 | 50.0% |
| 90471 | Administration of 1 vaccine | Office | 2020 | 13 | 14 | $420.00 | $108.05 | 25.7% |
About Dr. Glenn Davis, MD
Dr. Glenn Davis, MD is a Internal Medicine healthcare provider based in Mount Vernon, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932277654.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glenn Davis, MD has received a total of $34,170 in payments from pharmaceutical and medical device companies, with $3,752 received in 2024. These payments were reported across 1,288 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($33,672).
As a Medicare-enrolled provider, Davis has provided services to 780 Medicare beneficiaries, totaling 867 services with total Medicare billing of $13,745. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Mount Vernon, NY
- Active Since 12/01/2006
- Last Updated 11/17/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1932277654
Products in Payments
- FARXIGA (Drug) $3,346
- VRAYLAR (Drug) $1,620
- Vascepa (Drug) $1,247
- DUPIXENT (Biological) $1,004
- XARELTO (Drug) $950.58
- TRELEGY ELLIPTA (Drug) $934.94
- Ozempic (Drug) $918.78
- JARDIANCE (Drug) $900.88
- TRADJENTA (Drug) $893.98
- Creon (Drug) $878.82
- BREZTRI (Drug) $818.22
- UBRELVY (Drug) $795.76
- ELIQUIS (Drug) $730.39
- TRULICITY (Drug) $713.44
- GEMTESA (Drug) $592.15
- XIFAXAN (Drug) $570.10
- JANUVIA (Drug) $559.97
- INVOKANA (Drug) $534.84
- AREXVY (Drug) $521.40
- FASENRA (Biological) $515.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mount Vernon
Dr. Susie Norris, M.d, M.D
Internal Medicine — Payments: $24,053
Internal Medicine $24,053
Osman Qaiyum, M.d, M.D
Internal Medicine — Payments: $21,807
Internal Medicine $21,807
Dr. Frederick Carroll, M.d, M.D
Internal Medicine — Payments: $17,719
Internal Medicine $17,719
Dr. Justin Williams, D.o, D.O
Internal Medicine — Payments: $14,219
Internal Medicine $14,219
Dr. Megan Neely, M.d, M.D
Internal Medicine — Payments: $7,322
Internal Medicine $7,322
Jiahuai Tan, M.d, M.D
Internal Medicine — Payments: $6,008
Internal Medicine $6,008